Patent 7932431 was granted and assigned to Crescendo Biologics Limited on April, 2011 by the United States Patent and Trademark Office.
A genetically modified non-human mammal or cell characterised in that it does not comprise a nucleic acid sequence which itself encodes any endogenous immunoglobulin heavy chain constant region locus polypeptide.